These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

420 related articles for article (PubMed ID: 29674970)

  • 1. Hypothesis: The Psychedelic Ayahuasca Heals Traumatic Memories via a Sigma 1 Receptor-Mediated Epigenetic-Mnemonic Process.
    Inserra A
    Front Pharmacol; 2018; 9():330. PubMed ID: 29674970
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Evidence on the impairing effects of Ayahuasca on fear memory reconsolidation.
    Daneluz DM; Sohn JMB; Silveira GO; Yonamine M; Stern CA
    Psychopharmacology (Berl); 2022 Oct; 239(10):3325-3336. PubMed ID: 36069952
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Effects of Long-Term Ayahuasca Administration on Memory and Anxiety in Rats.
    Favaro VM; Yonamine M; Soares JC; Oliveira MG
    PLoS One; 2015; 10(12):e0145840. PubMed ID: 26716991
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Toxicokinetics and Toxicodynamics of Ayahuasca Alkaloids
    Brito-da-Costa AM; Dias-da-Silva D; Gomes NGM; Dinis-Oliveira RJ; Madureira-Carvalho Á
    Pharmaceuticals (Basel); 2020 Oct; 13(11):. PubMed ID: 33114119
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Understanding posttraumatic stress disorder through fear conditioning, extinction and reconsolidation.
    Careaga MBL; Girardi CEN; Suchecki D
    Neurosci Biobehav Rev; 2016 Dec; 71():48-57. PubMed ID: 27590828
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The pharmacological interaction of compounds in ayahuasca: a systematic review.
    Ruffell S; Netzband N; Bird C; Young AH; Juruena MF
    Braz J Psychiatry; 2020; 42(6):646-656. PubMed ID: 32638916
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Contextual Information Drives the Reconsolidation-Dependent Updating of Retrieved Fear Memories.
    Jarome TJ; Ferrara NC; Kwapis JL; Helmstetter FJ
    Neuropsychopharmacology; 2015 Dec; 40(13):3044-52. PubMed ID: 26062788
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Psychedelics and reconsolidation of traumatic and appetitive maladaptive memories: focus on cannabinoids and ketamine.
    Fattore L; Piva A; Zanda MT; Fumagalli G; Chiamulera C
    Psychopharmacology (Berl); 2018 Feb; 235(2):433-445. PubMed ID: 29178010
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Reconsolidation/destabilization, extinction and forgetting of fear memory as therapeutic targets for PTSD.
    Kida S
    Psychopharmacology (Berl); 2019 Jan; 236(1):49-57. PubMed ID: 30374892
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Calcineurin Promotes Neuroplastic Changes in the Amygdala Associated with Weakened Cocaine-Cue Memories.
    Rich MT; Huang YH; Torregrossa MM
    J Neurosci; 2020 Feb; 40(6):1344-1354. PubMed ID: 31862855
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Ceremonial Ayahuasca in Amazonian Retreats-Mental Health and Epigenetic Outcomes From a Six-Month Naturalistic Study.
    Ruffell SGD; Netzband N; Tsang W; Davies M; Butler M; Rucker JJH; Tófoli LF; Dempster EL; Young AH; Morgan CJA
    Front Psychiatry; 2021; 12():687615. PubMed ID: 34177670
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Transcriptional Regulation Involved in Fear Memory Reconsolidation.
    Wang X; Li M; Zhu H; Yu Y; Xu Y; Zhang W; Bian C
    J Mol Neurosci; 2018 Jun; 65(2):127-140. PubMed ID: 29796837
    [TBL] [Abstract][Full Text] [Related]  

  • 13. N,N-dimethyltryptamine and Amazonian ayahuasca plant medicine.
    James E; Keppler J; L Robertshaw T; Sessa B
    Hum Psychopharmacol; 2022 May; 37(3):e2835. PubMed ID: 35175662
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Metabolism and disposition of N,N-dimethyltryptamine and harmala alkaloids after oral administration of ayahuasca.
    Riba J; McIlhenny EH; Valle M; Bouso JC; Barker SA
    Drug Test Anal; 2012; 4(7-8):610-6. PubMed ID: 22514127
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Mechanisms of reconsolidation and extinction of fear memory].
    Kida S; Fukushima H; Mamiya N
    Nihon Shinkei Seishin Yakurigaku Zasshi; 2009 Jun; 29(3):125-33. PubMed ID: 19663263
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Ayahuasca: Pharmacology, neuroscience and therapeutic potential.
    Domínguez-Clavé E; Soler J; Elices M; Pascual JC; Álvarez E; de la Fuente Revenga M; Friedlander P; Feilding A; Riba J
    Brain Res Bull; 2016 Sep; 126(Pt 1):89-101. PubMed ID: 26976063
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Behavioral and pharmacokinetic interactions between monoamine oxidase inhibitors and the hallucinogen 5-methoxy-N,N-dimethyltryptamine.
    Halberstadt AL
    Pharmacol Biochem Behav; 2016 Apr; 143():1-10. PubMed ID: 26780349
    [TBL] [Abstract][Full Text] [Related]  

  • 18.
    Malcolm BJ; Lee KC
    Ment Health Clin; 2017 Jan; 7(1):39-45. PubMed ID: 29955496
    [No Abstract]   [Full Text] [Related]  

  • 19. [Posttraumatic stress disorder (PTSD) as a consequence of the interaction between an individual genetic susceptibility, a traumatogenic event and a social context].
    Auxéméry Y
    Encephale; 2012 Oct; 38(5):373-80. PubMed ID: 23062450
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Diverse therapeutic developments for post-traumatic stress disorder (PTSD) indicate common mechanisms of memory modulation.
    Raut SB; Marathe PA; van Eijk L; Eri R; Ravindran M; Benedek DM; Ursano RJ; Canales JJ; Johnson LR
    Pharmacol Ther; 2022 Nov; 239():108195. PubMed ID: 35489438
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 21.